This new technique could make TAVR more available

A novel technique could prevent coronary artery obstruction — a rare but often fatal complication related to transcatheter aortic valve replacement (TAVR), according to the National Institutes of Health researchers who created it. The researchers at NIH’s National, Heart, Lung, and Blood Institute are calling the procedure Bioprosthetic Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA).

The most disruptive medical device innovations of all time

When it comes to disruptive medical device innovations, it’s easy to lose the perspective of history. Here are devices through history that definitely made a difference. Chris Newmarker, Managing Editor and Danielle Kirsh, Assistant Editor Whether you’re talking about surgical robotics or efforts to bring more value to healthcare, the word “disruptive” seems to get

Pages: 1 2 3 4 5 6 7 8

3 secrets of medtech success from a true industry pioneer

From stents to TAVR, Stanton Rowe has built a medtech legacy out of accomplishing the seemingly impossible. Here are three lessons from his career. Stanton Rowe has played a major role in two of the top medtech innovation success stories of recent decades: stents and transcatheter valve replacements. Listening to him speak at DeviceTalks West

What is the future of medtech in 2018?

Some of the largest medtech companies showed in 2017 that they are ready to grow through embrace of the new healthcare ecosystem. Medical device companies are putting greater emphasis on value-based arguments for their products and services. They’re putting more attention to clinical and economic research and adopting digital products that incorporate machine learning and

Pages: 1 2 3 4 5 6 7 8

These 10 medtech companies care a lot about research

Among the world’s largest medtech companies, these 10 spent the largest portion of their budgets on research and development. So what have they produced? Every year, Medical Design & Outsourcing pulls financial regulatory filings and reaches out to major, companies in some cases to create a list of the 100 largest medical device companies in

Pages: 1 2 3 4 5 6 7 8 9 10 11

Should the medical device industry pay user fees to CMS?

Achieving reimbursement from payers has become a major challenge for medical device companies. Could the solution lie in having them pay user fees to CMS – the way they do to FDA? That was the question floated by Nadim Yared, president of CVRx and the current chairman of AdvaMed, during this week’s Medtech Conference powered by

Edwards Lifesciences has ‘key events’ around TAVR this week

Edwards Lifesciences is planning some important TAVR reveals during the PCR London Valves 2017 course that is underway. The Irvine, Calif.–based cardio devices company said yesterday that it plans to introduce the new Sapien 3 Ultra valve during the event, which runs until tomorrow. Edwards officials expect the Sapien 3 Ultra to receive CE Mark